Toxicology Drug Screening Market Report: Trends, Forecast and Competitive Analysis to 2030

Toxicology Drug Screening Market Report: Trends, Forecast and Competitive Analysis to 2030

Toxicology Drug Screening Trends and Forecast

The future of the global toxicology drug screening market looks promising with opportunities in the hospitals and trauma centers, forensic laboratories, diagnostic laboratories, rehabilitation centers, and pharmaceutical & biotechnology companies markets. The global toxicology drug screening market is expected to reach an estimated $22.7 billion by 2030 with a CAGR of 8.5% from 2024 to 2030. The major drivers for this market are increasing research and development (R&D) expenditure, technological advancements in toxicity screening, and growing use of in vitro techniques to identify harmful medications in the human body.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Toxicology Drug Screening by Segment

The study includes a forecast for the global toxicology drug screening by technology, type, test type, end use, and region.

Toxicology Drug Screening Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• High-Throughput Screening
• Genomics
• Transcriptomics
• Toxicogenomics
• Molecular Screening

Toxicology Drug Screening Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Cardiovascular Disease Drug Screening
• Obesity Drug Screening
• Diabetes Drug Screening
• Others

Toxicology Drug Screening Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

• Acute Systemic Toxicity
• Dermal Toxicity
• Carcinogenicity
• Ocular Toxicity
• Genotoxicity
• Neurotoxicity
• Organ-Specific Toxicity

Toxicology Drug Screening Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals and Trauma Centers
• Forensic Laboratories
• Diagnostic Laboratories
• Rehabilitation Centers
• Pharmaceutical & Biotechnology Companies

Toxicology Drug Screening Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Toxicology Drug Screening Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies toxicology drug screening companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the toxicology drug screening companies profiled in this report include-

• Agilent Technologies
• Covance
• Bio-Rad Laboratories
• General Electric Company
• BioReliance
• Thermo Fisher Scientific
• Eurofins Scientific
• GE Healthcare
• Quest Diagnostics
• Enzo Life Sciences

Toxicology Drug Screening Market Insights

Lucintel forecasts that high-throughput screening is expected to witness the highest growth over the forecast period.

Within this market, diagnostic laboratories is expected to witness the highest growth because it offers a large range of tests for illness monitoring and diagnosis, making them crucial to the healthcare process.

North America will remain the largest region over the forecast period due to high incidence of chronic illnesses, significant investments in R&D, a firmly established network of diagnostic laboratories, and a sophisticated healthcare infrastructure in the region.

Features of the Global Toxicology Drug Screening Market

Market Size Estimates: Toxicology drug screening market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Toxicology drug screening market size by technology, type, test type, end use, and region in terms of value ($B).

Regional Analysis: Toxicology drug screening market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technology, type, test type, end use, and regions for the toxicology drug screening market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the toxicology drug screening market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the toxicology drug screening market size?

Answer: The global toxicology drug screening market is expected to reach an estimated $22.7 billion by 2030.

Q2. What is the growth forecast for toxicology drug screening market?

Answer: The global toxicology drug screening market is expected to grow with a CAGR of 8.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the toxicology drug screening market?

Answer: The major drivers for this market are increasing research and development (R&D) expenditure, technological advancements in toxicity screening, and growing use of in vitro techniques to identify harmful medications in the human body.

Q4. What are the major segments for toxicology drug screening market?

Answer: The future of the global toxicology drug screening market looks promising with opportunities in the hospitals and trauma centers, forensic laboratories, diagnostic laboratories, rehabilitation centers, and pharmaceutical & biotechnology companies markets.

Q5. Who are the key toxicology drug screening market companies?

Answer: Some of the key toxicology drug screening companies are as follows:

• Agilent Technologies
• Covance
• Bio-Rad Laboratories
• General Electric Company
• BioReliance
• Thermo Fisher Scientific
• Eurofins Scientific
• GE Healthcare
• Quest Diagnostics
• Enzo Life Sciences

Q6. Which toxicology drug screening market segment will be the largest in future?

Answer: Lucintel forecasts that high-throughput screening is expected to witness the highest growth over the forecast period.

Q7. In toxicology drug screening market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high incidence of chronic illnesses, significant investments in R&D, a firmly established network of diagnostic laboratories, and a sophisticated healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the toxicology drug screening market by technology (high-throughput screening, genomics, transcriptomics, toxicogenomics, and molecular screening), type (cardiovascular disease drug screening, obesity drug screening, diabetes drug screening, and others), test type (acute systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, genotoxicity, neurotoxicity, and organ-specific toxicity), end use (hospitals and trauma centers, forensic laboratories, diagnostic laboratories, rehabilitation centers, and pharmaceutical & biotechnology companies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Please note: It will take 2-3 business days to deliver the report upon receipt the order.